Clinical Trials Browser

Phase 1/2 × Completed × HLA-A*24:02 antigen × Clear all

NCT01949688 2019-03-19

Safety and Efficacy Study of Epitope Peptide To Treat HLA-A24 or A02-positive Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumors